- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01357928
Thromboelastography (TEG) Reference Range Study
September 4, 2012 updated by: Haemonetics Corporation
Procedure for the Reference Range Study for Haemoscope Reagents
As part of a system wide reagent verification plan Haemoscope Corporation will be running a study to verify the reference intervals of many of the reagents.
Reference intervals will be constructed following the guidelines set out in CLSI document C28-A3c.
This guideline calls for a reference interval to be constructed from at least 120 donors.
Some reagents currently have ranges in place based on fewer donors than that stated in the guideline.
This procedure will provide additional testing results to meet the requirements outlined in the CLSI guideline.
Reagents that currently have no reference intervals will be tested and will include a minimum of 146 donors.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
159
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Manhasset, New York, United States, 11030
- North Shore-Long Island Jewish Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
community sample
Description
Inclusion Criteria:
- Male or Female over the age of 18 years.
Exclusion Criteria:
- Genetic bleeding disorders
- Currently Pregnant
- Oral Contraceptives
- On anti-coagulants or anti-platelet therapy
- Took ASA (Acetylsalicylic Acid)within 1 week prior
- Recent surgery (within 4 weeks)
- Recent injury leading to substantial bruising (within 2 weeks)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Healthy Volunteers
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: William A Heaton, M.D., NSLIJ Health System
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (ACTUAL)
July 1, 2011
Study Completion (ACTUAL)
October 1, 2011
Study Registration Dates
First Submitted
May 19, 2011
First Submitted That Met QC Criteria
May 20, 2011
First Posted (ESTIMATE)
May 23, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
September 5, 2012
Last Update Submitted That Met QC Criteria
September 4, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TP-CLN-100048C
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coagulation
-
Masaryk Hospital Krajská zdravotní a.s.CompletedCoagulation Disorder | Multiple Trauma | Coagulation Defect; Acquired | Coagulation Factor DeficiencyCzechia
-
Medical University of ViennaEuropean Society of Anaesthesiology; Medical Scientific Fund of the Mayor of...Completed
-
HemoSonics LLCCompletedCoagulationUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
Kyowa Kirin Co., Ltd.CompletedDisseminated Intravascular Coagulation (DIC)Japan
-
University Hospital, GhentUniversity GhentCompletedHemodialysis | CoagulationBelgium
-
Hospices Civils de LyonCompleted
-
PfizerCompletedBlood CoagulationUnited States
-
Lawson Health Research InstituteAcademic Medical Organization of Southwestern OntarioCompleted